An effective strategy was developed to fabricate the novel dually thermo- and pH-responsive yolk/shell polymer microspheres as a drug delivery system (DDS) for the controlled release of anticancer drugs via two-stage distillation precipitation polymerization and seed precipitation polymerization. Their pH-induced thermally responsive polymer shells act as a smart "valve" to adjust the diffusion of the loaded drugs in/out of the polymer containers according to the body environments, while the movable P(MAA-co-EGDMA) cores enhance the drug loading capacity for the anticancer drug doxorubicin hydrochloride (DOX). The yolk/shell polymer microspheres show a low leakage at high pH values but significantly enhanced release at lower pH values equivalent to the tumor body fluid environments at human body temperature, exhibiting the apparent tumor-environment-responsive controlled "on-off" drug release characteristics. Meanwhile, the yolk/shell microspheres expressed very low in vitro cytotoxicity on HepG2 cells. Consequently, their precise tumor-environment-responsive drug delivery performance and high drug loading capacity offer promise for tumor therapy.
No takes yet. Share an insight, caveat, or question.
Du et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: